Biotechnology & Drugs news, Biotechnology & Drugs industry, industry News

▮ More

First Treatment Option Approved For Patients With Epithelioid Sarcoma

Genentech: Tecentriq Fails To Meet Primary Endpoint In Phase III Study

Intuitive Surgical Inc. Q4 adjusted earnings Beat Estimates

ABH Pharma, Stocknutra Recalling Dietary Supplement Products

Abbott Announces Positive Results In Chronic Pain Study

Merck : Canada Oks KEYTRUDA As First-Line Treatment For Advanced RCC

Genentech's Risdiplam Meets Primary Goal In Type 1 Spinal Muscular Atrophy Trial

CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC

Abbott Laboratories Q4 adjusted earnings Inline With Estimates

Johnson & Johnson Q4 adjusted earnings Beat Estimates

CRH Medical (CRHM) Hits New High, Up 18% In A Month

Tissue Regenix Group Sees FY Revenue To Be £13 Mln, Up 12%

Alliance Pharma Sees FY Underlying Pre-tax Profit In Line With View

Basilea Reaches Agreement With Roche On Planned Study In Gastric Cancer

Frequency Therapeutics Making The Right Noises, IPO Lockup Expires On Mar.31

First Drug For TED Secures Approval, TROV On Watch, EVOK Faces FDA In June

CIT Group To Replace Tanger Factory Outlet In S&P MidCap 400

GSK : FDA Grants Priority Review Of Belantamab Mafodotin On Multiple Myeloma

Seattle Genetics Achieves Milestone On EU Approval Of Roche's Polivy

Xilinx Sues Analog Devices Alleging Infringement Of Eight Patents - Quick Facts

PetMed Express Inc. Profit Drops In Q3

Novavax (NVAX) Gains Over 46% In 5 Days, To Report Phase 3 NanoFlu Data In Q1

Roche : EU Okays Polivy For People With Previously Treated Aggressive Lymphoma

Lonza FY19 Profit Climbs, Sees Sales Growth In FY20; Confirms Mid-term 2022 View

Roche: EC Grants Conditional Marketing Authorisation For Polivy

Industries >>

Biotechnology & Drugs News

Tissue Regenix Group Sees FY Revenue To Be £13 Mln, Up 12%

Alliance Pharma Sees FY Underlying Pre-tax Profit In Line With View

Roche: EC Grants Conditional Marketing Authorisation For Polivy